Form a licensing agreement with Goldsol to manufacture and distribute the product
The antimicrobial properties of silver have been known for centuries, but the recent use of ionic and colloidal silver for antibacterial applications has been plagued with inferior products, scientific confusion and debatable marketing claims. But Goldsol, through a cooperation with nano technology university researchers, has released Microbisil, a new nano silver formulation that features a 25,000ppm and higher concentration stable silver colloidal solution for antimicrobial applications.
Goldsol is a US metals nanotechnology development company based in Phoenix, Arizona that develops nano gold, silver, copper and other nano metals which can be applied in a number of fields including flexible electronics.
The Microbisil formula is said to be unique in that it includes 10nm silver particles which are coated with a proprietary substance, so that they remain suspended, even at very high concentrations. The concentration is so high that the solution becomes almost black, the company says.
The use of a coating agent is important for the colloid solution to remain stable in complex liquids such as juices, soups or soft drinks. The coating agent also protects the silver from being chemically active while allowing a slow release of silver ions more than enough to achieve antibacterial concentrations and makes the nanoparticles safe in living organisms. Particle size uniformity also contributes to its safe qualities.
Goldsol says other colloidal silver products on the market are not suitable for these applications due to stability, uniformity and concentration issues of the silver particles. Unless coated, the particles are not stable or safe and a low concentration makes it very difficult to scale up production or transport them a convenient way.
'We believe that our technologically advanced manufacturing process of Microbisil may finally provide a functional, reliable and cost-effective solution for antimicrobial applications,' the researchers say.
They also claim their technological process is easily scalable to high volume commercial production.
Goldsol has entered into an exclusive licensing agreement with the Microbisil nanotechnology university researchers to manufacture and distribute the product.
'Our mission is to develop the most advanced metal nano-materials available,' said Steve Crimi, Goldsolís CEO. 'In the case of Microbisil, itís not just about making another colloidal silver. It is also about making it safe, stable and highly concentrated for easy distribution around the world. There is no doubt that our new silver is a major breakthrough.'
However, Crimi says several key strategic partnerships need to happen for Microbisil to reach mass adoption. The company is therefore approaching and forming strategic alliances with key industry or healthcare partners in an effort to develop solutions for the worldwide antimicrobial applications of silver.
It is anticipated that, by 2020, safe, reliable, concentrated and inexpensive silver drops will be placed in many drinks, extending shelf life of products and preventing outbreaks of infections in both first and third world countries.